Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Offices

Amsterdam, ANT
Pilotenstraat 45
Amsterdam, 1059 CH, ANT

People

Funding

TOTAL $6M
FUNDING TOTAL $6M
Venture Round, 2012
$3.8M
Venture Round, 2/2014
Friends and Family
$2.2M

Tags

myTomorrows

myTomorrows is a Dutch startup that wants to disrupt the way patients with unmet medical needs access to development-stage treatments — drugs that are still undergoing clinical trials and working there way through a lengthy regulatory approval process. It targets patients who are typically up against time (e.g. specific types of cancer) and for whom drugs that could prolong or improve their quality of life do sometimes exist but aren’t yet “approved” and readily available on the market, even though positive trials have been conducted. Right now, how a patient accesses these treatments is somewhat of a lottery, if they can access them at all. By providing a platform that connects patients, doctors and drugs companies, myTomorrows wants to change that.

Recent Milestones

Videos

Screenshots

myTomorrows screenshot
Above: Homepage
Uploaded: 2/19/14

Sources

  1. Citation Needed [add]
  2. myTomorrows Raises $2.2M For Platform To Give Patients Access To Development-Stage Drugs (techcrunch.com) [edit]
Edit This Page
Last Edited 2/19/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

TechCrunch Posts TechCrunch Logo Small Picture

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy